Harvest Group Wealth Management, LLC Neurocrine Biosciences Inc Transaction History

Harvest Group Wealth Management, LLC

  • $154 Million
  • Q1 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 27, 2023
BUY
$106.72 - $127.06 $533 - $635
5 Added 83.33%
11 $1,000
Q3 2022

Nov 08, 2022
BUY
$92.03 - $107.81 $552 - $646
6 New
6 $1,000
Q1 2022

Apr 21, 2022
SELL
$72.45 - $94.81 $869 - $1,137
-12 Closed
0 $0
Q4 2021

Jan 21, 2022
BUY
$79.65 - $106.22 $955 - $1,274
12 New
12 $1,000

Others Institutions Holding NBIX

# of Institutions
624
Shares Held
94.2M
Call Options Held
632K
Put Options Held
621K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.8B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Harvest Group Wealth Management, LLC Portfolio

Follow Harvest Group Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Group Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Group Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email